tirzepatide gila monster How a Canadian scientist and a venomous lizard helped pave the way for Ozempic We wouldn't have Ozempic without

Grade Study Research Group, Nathan DM, Lachin JM, Balasubramanyam A, Burch HB, Buse JB, Butera NM, Cohen RM, Crandall JP, Kahn SE, Krause-Steinrauf H, Larkin ME, Rasouli N, Tiktin M, Wexler DJ, Younes N, The GSRG

Ready to try the MindBody GLP-1 System

The information in this article applies only to their approved uses and is for informational purposes only

Limited Visibility In a 1:1 matched case-control study performed by Chapman et al., patients getting GLP-1 RAs had significantly lower visibility scores during EGD and were 4.62 times more likely to have retained gastric contents compared to patients not on GLP-1 RAs ( p -value 0.025) [23]

This is from driving to and from the office, sitting in the waiting room next to sick people, sitting in the office and then spending 3-5 minutes with the nurse before maybe seeing the physician